47.73.Z - Retail sale of pharmaceutical products
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,1 | -84,7 | ||
Gross profit (loss) | 0,2 | -2,2 | -2,4 | -10,3 |
EBITDA | 0,3 | -1,9 | -2 | -3 |
Short time liabilities | 2 | 6,6 | 6,4 | -2 |
Other operating costs | 0 | -79,9 | ||
Equity capital | -0 | -2,2 | -2,3 | -5,7 |
Operating profit (EBIT) | 0,2 | -2,1 | -2 | 3,2 |
Assets | 2 | 6,2 | 7,7 | 23,5 |
Net profit (loss) | 0,2 | -2,2 | -2,4 | -10,3 |
Cash | 0,8 | 0,8 | 1 | 20,5 |
Net income from sale | 13 | 12,7 | 24,6 | 93,3 |
Liabilities and provisions for liabilities | 2,1 | 8,4 | 10 | 18,8 |
Working assets | 1,9 | 6 | 7,4 | 24,4 |
Other income costs | 0,4 | 237 523,7 | ||
Depreciation | 0 | 0,2 | 0,1 | -67,7 |
% | % | % | p.p. | |
Profitability of capital | -1515,2 | 99,3 | 103,5 | 4,2 |
Equity capital to total assets | -0,8 | -35,5 | -30,4 | 5,1 |
Gross profit margin | 1,9 | -17,2 | -9,8 | 7,4 |
EBITDA Margin | 2 | -15 | -8 | 7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 57 | 188 | 96 | -92 |
Current financial liquidity indicator | 0.9606969356536865 | -0,1 | ||
Net dept to EBITDA | -2.6498959064483643 | -5,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane